Full-Time

Prior Authorization Supervisor

Specialty Testing

Posted on 10/3/2025

Deadline 10/24/25
LabCorp

LabCorp

10,001+ employees

Global life sciences R&D services

Compensation Overview

$52.2k - $92.6k/yr

No H1B Sponsorship

Remote in USA

Remote

Category
Operations & Logistics (2)
,
Required Skills
Word/Pages/Docs
Customer Service
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • High school diploma or equivalent required; associate degree or higher strongly preferred.
  • Minimum 3 years of relevant work experience required.
  • Minimum 1 year of experience in prior authorizations strongly preferred (concurrent experience acceptable).
  • 3+ years of leadership experience strongly preferred.
  • Minimum 2+ years prior work experience in insurance claims, pre-authorization, and medical benefits strongly preferred.
  • Utilize MS Excel, Word and Outlook; PowerPoint proficiency preferred.
  • Experience with specialty testing (such as oncology, women's health, and other advanced diagnostics) preferred.
  • Proven ability to identify improvement opportunities and implement recommendations preferred.
Responsibilities
  • Oversee work assignments, ensuring efficient task distribution and timely completion.
  • Generate and analyze inventory reports to guide decision-making.
  • Proactively assess inventory throughout the day to optimize workflow and prioritize urgent cases.
  • Communicate effectively with various departments to resolve discrepancies, including missing work files and IT platform issues.
  • Audit employee work for accuracy, providing constructive feedback and coaching to enhance performance.
  • Conduct one-on-one meetings with employees, fostering professional growth and setting annual goals.
  • Offer timely support by answering employee and stakeholder inquiries.
  • Train new hires and develop comprehensive training resources.
  • Create and interpret complex SOPs, job aids, and special workflows for diverse processes.
  • Design and lead engaging team meetings.
  • Navigate multiple platforms and websites to facilitate prior authorization tasks.
  • Perform specimen history research to assist with escalations, training, and troubleshooting.
  • Deliver exceptional customer service with professionalism, patience, and empathy.
  • Escalate critical issues to leadership when necessary.
  • Identify and recommend process improvements to enhance efficiency.
  • Maintain a thorough understanding of policies, guidelines, and payer requirements related to specialty testing (such as oncology, women's health, and other advanced diagnostics).
  • Ensure compliance with specialty test regulations and proactively address any policy updates that impact workflow.
  • Meet deadlines consistently while maintaining high accuracy and minimal errors.
  • Complete required trainings punctually and thoroughly.
Desired Qualifications
  • Exceptional interpersonal communicator with the ability to build rapport and motivate teams.
  • Strong problem-solving and decision-making abilities.
  • Detail-oriented with a proven track record of delivering results.
  • Comfortable managing performance in a production-driven environment while enforcing company policies.
  • Demonstrates integrity, trustworthiness, accountability, and respect in all professional interactions.
  • Maintains confidentiality and upholds high ethical standards.
  • Strong verbal and written communication skills.
  • Self-motivated with the ability to thrive under pressure in a dynamic environment.
  • Reliable and punctual.

Labcorp provides end-to-end R&D services for life sciences and agricultural clients, including crop protection, with testing and regulatory support. It runs physicochemical analyses, safety assessments, and inhalation toxicology studies using specialized labs to evaluate inhaled substances. It differentiates itself with a global footprint and an integrated set of services across the product lifecycle, including regulatory submissions. Its goal is to help clients bring safe, effective products to market efficiently by applying rigorous science and scalable testing.

Company Size

10,001+

Company Stage

IPO

Headquarters

Burlington, Vermont

Founded

1976

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue hit $3.54B, up 5.8%, raising full-year guidance to $14.73B.
  • AI Alzheimer's platform validates spring 2026, expands to oncology and cardiometabolic areas.
  • Optum.ai partnership automates lab workflows and enhances patient engagement.

What critics are saying

  • Quest Diagnostics outgrows Labcorp at 9.2% versus 5.8%, eroding diagnostics share in 6-12 months.
  • NeoGenomics seizes oncology volume with 11.1% growth, hitting Labcorp's specialty testing now.
  • Tempus commoditizes Labcorp's AI platform with superior EHR integration in 24 months.

What makes LabCorp unique

  • Labcorp's AI platform with AWS and Datavant analyzes Alzheimer's data in minutes using deidentified lab datasets.
  • Labcorp holds first FDA clearance for rapid fentanyl urine test in emergency settings.
  • Labcorp's Plasma Detect Genome MRD assesses NSCLC recurrence risk via whole-genome sequencing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Unlimited Paid Time Off

Tuition Reimbursement

Employee Stock Purchase Plan

Company News

360Dx
May 5th, 2026
Fox Chase Cancer Center, Labcorp collaborate on clinical trial for Plasma Detect Genome MRD in NSCLC.

Fox Chase Cancer Center, Labcorp collaborate on clinical trial for Plasma Detect Genome MRD in NSCLC. NEW YORK - Temple Health's Fox Chase Cancer Center and Laboratory Corporation of America announced Tuesday a clinical trial collaboration to evaluate the use of Labcorp's whole-genome sequencing Plasma Detect Genome MRD to assess the risk of recurrence in patients with early stage non-small cell lung cancer (NSCLC). Get the full story with 360dx Premium. Only $95 for the first 90 days. Full site access Interest-based email alerts Premium Access - Trial Offer $95.00 for 3 month

Resonate Group
Apr 15th, 2026
Labcorp launches rapid fentanyl test with 48-hour detection window.

Labcorp launches rapid fentanyl test with 48-hour detection window. * April 15, 2026 While fentanyl overdose deaths have been falling in recent years, use of the drug remains a major public health crisis in the U.S., and now Labcorp is launching a new test designed to detect the drug's use for up to 48 hours after exposure. Fields (*) Mark are Required

PR Newswire
Apr 14th, 2026
Labcorp launches AI-powered platform with AWS and Datavant to accelerate Alzheimer's research

Labcorp has launched an AI-powered real-world data platform to accelerate Alzheimer's disease research, developed in collaboration with Amazon Web Services and Datavant. The platform aims to generate insights in minutes that previously required months of data analysis. The system combines Labcorp's diagnostic and genomic datasets with medical claims data, using AWS AI services including Amazon Bedrock and Amazon SageMaker. It enables researchers to identify patient cohorts, track disease progression and measure treatment effectiveness across diverse populations using deidentified healthcare data. With over 7.2 million Americans living with Alzheimer's and annual care costs exceeding $380 billion in the US, the platform addresses traditional challenges of fragmented data and lengthy preparation times. Initial validation will complete in spring 2026, with plans to expand into inflammatory diseases, cardiometabolic conditions, women's health and oncology.

360Dx
Apr 13th, 2026
Labcorp, CHOP to develop, commercialize specialty pediatric diagnostics.

Labcorp, CHOP to develop, commercialize specialty pediatric diagnostics. NEW YORK - Laboratory Corporation of America and Children's Hospital of Philadelphia (CHOP) on Monday announced a strategic collaboration to accelerate the development of and access to specialized pediatric diagnostics. Get the full story with 360dx Premium. Only $95 for the first 90 days. Full site access Interest-based email alerts Premium Access - Trial Offer $95.00 for 3 month

360Dx
Mar 20th, 2026
In brief this week: Labcorp, guardant Health, waters, fulgent genetics, more.

In brief this week: Labcorp, guardant Health, waters, fulgent genetics, more. NEW YORK - Laboratory Corporation of America this week said it has completed its acquisition of select assets of Crouse Health's Laboratory Alliance of Central New York's laboratory business. The two firms also have entered into a deal for Crouse Health to manage the daily operations of its inpatient lab, while Labcorp will take over operations of the lab alliance's 12 patient service centers. It said in a statement that the deal will improve access to high-quality, affordable diagnostic services in Central New York by offering patients and providers Labcorp's expanded testing menu, data, and digital tools. To read the full story... What's Popular?

INACTIVE